NEW YORK (360Dx) – Laboratory Corporation of America has completed its previously announced $1.2 billion cash acquisition of contract research organization Chiltern, which will become part of the company's Covance drug development business.
NEW YORK (360Dx) – Laboratory Corporation of America has completed its previously announced $1.2 billion cash acquisition of contract research organization Chiltern, which will become part of the company's Covance drug development business.
...and receive Daily News bulletins.
Already have a 360Dx or GenomeWeb account?
Login Now.
Don't have a 360Dx or GenomeWeb account?
Register for Free.